Mr. Liu is the founder of China Sky One. Before establishing the company, he had 10 years of experience in drug marketing, R&D, and enterprise management. He also has eight years of experience as a reporter of Family Health Newspaper. He has been instrumental in establishing TDR¡¯s sales program and network in China. Mr. Liu graduated from the Prophylactic Department of Harbin Medical University, where he obtained his bachelor¡¯s degree. In 2005, he studied at Tsing Hua University and earned Executive Master of Business. Mr.Liu owns 4,665,493 shares, or 29.4% of common shares outstanding.
¡¡Xiao-Yan Han, COO and Vice-President
Ms. Han had five years of hygiene and medical media experience before joining TDR. She has been instrumental in developing and marketing TDR¡¯s products and expanding its sales. She serves as a senior marketing manager and administrative manager and has 10 years of financial management experience. In 2004, she was appointed the general manager of TDR, with responsibility for financing, production, quality control and purchasing. In 2003, she was appointed director of Harbin First Bio-Engineering. She received Master of Business Administration at Harbin Industrial University in 2004. Ms. Han Xiao-yan owns 1,406,717 shares, 8.9% of outstanding shares.
Yu-bo Hao, Chief Financial Officer, Director, and Board Secretary
Mr. Hao has been worked
as CFO at China Sky One since December, 2008. From January, 2006, to March, 2008, he served as
President¡¯s Assistant and Financial Officer for Sumitomo Group Canadian Branch. Prior to Sumitomo,
Mr. Hao served as Marketing Executive and Canadian Market Analyst for MGM Mirage from September, 2004, to December, 2005. From September, 1997, to October, 2001, he was co-founder and CEO of
SunnyZone Consulting Co. Ltd. Mr. Hao holds a Bachelor¡¯s degree in Economics & Arts from Beijing
Union University and an MBA from the University of Phoenix.
¡¡Chun-Fang Song, Director
Mr. Song joined the board of directors on February 22, 2008. From 1964 to the present, Song Chun Fan has been employed by the First Clinical College of Harbin Medical University in Heilongjiang, China, where he has served as the Director of the Surgery Research Department and the Director of Graduate Studies of the Surgery Department since 1996. From 1998 to the present, he has been the acting Director of the Heilongjiang Professional Surgery Committee, the Commissary of the Degree Commission of China, the Director of the Key Laboratory of Cell Transplantation of the Ministry of Public Health of China, the Vice-Chairman of the Heilongjiang Medicine Association, the Vice-Chairman of the Heilongjiang Physician Association, and the Director of Heilongjiang (Special) Medical Treatment Application Administration Committee. He received a Bachelor¡¯s Degree in Medical Treatment from Harbin Medical University in 1964.
¡¡Wei Lee, Director.
Mr. Lee has over 15 years of experience in financial services and government relations, including investments, joint ventures, mergers & acquisitions and management consulting. From 2000 to 2002 he was a Senior Associate at McKinsey Management Consulting Co. Ltd. and in 2003 he was a Project Manager at Roland Berger Strategy Consultants Ltd. From 2004 to 2006, he served as Director of Strategic Development at TNT N.V., an Amsterdam-based provider of postal and logistics services, where he was responsible for M&A and China business strategy. Since 2007, Mr. Wei Lee has been a Managing Director with Transworld Capital Group, a U.S. investment service firm specializing in cross-border M&A and fund raising between U.S. and China. In 2008, he served as Chief Operating Officer (on loan) for Legend Media Corporation, a U.S.-listed company specializing in radio advertising in China. Mr. Wei Lee earned a Master's degree in Political Science from North Illinois University in 1989 and a Ph.D. in Political Science from Massachusetts Institute of Technology in 1994, where he completed MBA course work at Sloan School. He completed post-doctoral studies at the Fairbank Center for East Asia Studies, Harvard University, in 1995.
¡¡Zhao Jie, Director
Mr. Zhao joined the board of directors on February 22, 2008. Since 1999, he has served as Tissue Specialist of the Replant Department of Capital Health Transplant Services in Alberta, Canada, responsible for various aspects of tissue transplantation, including determining donee acceptability, processing and preserving tissue, performing surgical procedures, and quality control. He received a Bachelor¡¯s Degree in Medicine from Harbin Medical University in 1988.
¡¡Xu-Feng Qian, Director.
Ms. Qian joined the board of directors on February 22, 2008. Since 2005, she has been employed by Moody¡¯s Investors Service and currently serves as a Vice President and Senior Analyst. Prior to that, she was the Research Fellow of the Furman Center for Real Estate and Urban Policy of New York University, where she conducted empirical quantitative research in various aspects of commercial and residential properties. From 1990 to 1996, she was an Assistant Professor of Economics at the Beijing Normal University. She received a Ph.D. in Economics from Rutgers University in 2004, a Masters Degree in Accounting from City University of New York in 1999, and a Bachelor¡¯s Degree in Economics from Beijing Normal University in 1990.
¡¡Yan-Qing Liu, Chairman&CEO
